Cefotype-CV 325 Tablet
Cefotype-CV 325 Tablet
MRP Rs.: 180/-
Packaging: 1x6x10 Strip
Cefpodoxime 200 mg + Clavulanic acid 125 mg
Description
Cefpodoxime 200 mg and Clavulanic acid 125 mg Tablet
Zoypod-CV-325 A brand of Cefpodoxime and Clavulanic acid combination are effective against multiple infections. The pharmacological action of Clavulanic acid prevents hydrolysis of Cefpodoxime against beta-lactamase secreting microbes and increases the antibiotic spectrum.
- Cefpodoxime 200 mg
Cefpodoxime 200mg Tablet is a broad-spectrum antibiotic used to treat a variety of infections caused by bacteria like pneumonia, sinusitis, cystitis and ear infections. Cefpodoxime Tablet works by inhibiting the bacterial cell wall synthesis. This medicine is not recommended for use in case of common cold, flu or viral infections since it is active against infections caused by bacteria only. Use of this medicine in infants less than 2 months of age is not recommended.
- Calvunic acid 125mg
Clavulanic acid is a β-lactam drug that functions as a mechanism-based β-lactamase inhibitor. While not effective by itself as an antibiotic, when combined with penicillin-group antibiotics, it can overcome antibiotic resistance in bacteria that secrete β-lactamase, which otherwise inactivates most penicillins.
For treatment of Respiratory tract infections (Adults):
Consider administration of 100-200 mg of Cefpodoxime and Clavulanic acid, every 12 hours.
For treatment of Respiratory tract infections (Pediatrics):
For children, consider administration of 8-10 mg/kg/day in two divided doses. The maximum dosage should not exceed 400 mg/day.
For treatment of Urinary tract infections (Adults):
Consider administration of 100-200 mg of Cefpodoxime and Clavulanic acid, every 12 hours.
For treatment of Urinary tract infections (Pediatrics):
For children, consider administration of 8-10 mg/kg/day in two divided doses. The maximum dosage should not exceed 400 mg/day.
For Skin infections (Adults):
Consider administration of 200-400 mg of Cefpodoxime and Clavulanic acid, every 12 hours.
For Skin infections (Pediatrics):
For children, consider administration of 8-10 mg/kg/day in two divided doses. The maximum dosage should not exceed 400 mg/day.
For Otitis media (Pediatrics):
For children, consider administration of 8-10 mg/kg/day in two divided doses. The maximum dosage should not exceed 400 mg/day.
For Uncomplicated gonorrhoea (Adults):
Consider administration of 200 mg of Cefpodoxime and Clavulanic acid.
Cefotype-CV-325 should be taken preferably with meals
